Autologous T-Cell Therapy Promising in Advanced Sarcoma – Oncology Nurse Advisor
Oncology Nurse Advisor |
Autologous T–Cell Therapy Promising in Advanced Sarcoma
Oncology Nurse Advisor CHICAGO — Infusion of autologous HER2-CAR T cells after lymphodepletion is safe and appears to be associated with objective clinical benefit in patients with advanced HER2+ sarcoma, according to the findings of a small phase I study presented at the … |
Medical Daily |
Immunotherapy drug effective for metastatic triple negative breast cancer
Science Daily The immunotherapy drug pembrolizumab — already FDA-approved for other forms of cancer-has been found to be effective in patients with metastatic triple negative breast cancer, according to an international clinical trial led by NYU Langone’s … Treatment For Triple Negative Breast Cancer; Immunotherapy Drug …Medical Daily |
|
Next-generation sequencing test identifies pathogens quickly in stem cell transplant patients
Healio NEW ORLEANS — A novel, next-generation sequencing plasma assay identified a broad range of infections more quickly than conventional tests in stem cell transplant patients, researchers said. |
|
CAR T-cell immunotherapy prompts durable response for ALL
Healio CHICAGO — Young patients with extramedullary relapse of acute lymphoblastic leukemia achieved potent and durable responses to single-agent chimeric antigen receptor T-cell immunotherapy, according to data presented at the ASCO Annual Meeting. |
|
Saturday at ASCO: promising immunotherapy combination data, but no home runs
Medical Marketing and Media As thousands of people descended upon Chicago this weekend for the American Society of Clinical Oncology’s annual meeting, some of the most pressing questions focused on how clinical trials treating non-small cell lung cancer with immunotherapy … |
Big Think |
CRISPR May Cause Hundreds of Unintended Mutations Into the Genome, New Study Finds
Big Think In case you haven’t already heard of CRISPR-Cas9, it is the revolutionary gene-editing technology, discovered just a few years ago, that allows scientists to edit the DNA of any species with an unprecedented precision and efficiency. Today, thousands … Off target mutations in CRISPR reported by whole … – Biotechin.AsiaBiotechin.Asia |